ArticleNucleic acids research2026
Benchmarking sketching methods on spatial transcriptomics data.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
3 authors.
Funding
Abstract
High-throughput spatial transcriptomics (ST) now profiles hundreds of thousands of cells or locations per section, creating computational bottlenecks for routine analysis. Sketching, or intelligent sub-sampling, addresses scale by selecting small, representative subsets. While effective for single-cell RNA sequencing data, existing sketching methods, which optimize coverage in expression space but ignore physical location, can introduce spatial bias when applied to ST data. To explore the impact of sketching on ST analysis, we systematically benchmarked uniform sampling, leverage-score sampling, Geosketch (minimax/Hausdorff), and scSampler (maximin) across multiple real ST datasets (mouse ovary, MERFISH brain, human breast cancer, lung) and simulations, using three input representations: Principle Component Analysis (PCA) embeddings, spatial coordinates, and spatially smoothed embeddings. We show that expression-only designs capture global transcriptomic heterogeneity but distort tissue architecture by over-sampling high-variability regions and under-sampling homogeneous areas. Coordinate-only sampling restores tissue coverage but misses transcriptional extremes. A simple spatially aware extension, computing leverage scores from a randomized singular value decomposition (SVD) basis smoothed by a spatial weights matrix, strikes a favorable balance, recovering rare cell states while maintaining uniform tissue coverage and avoiding edge effects. Across robust Hausdorff distances, clustering stability (Adjusted Rand Index), PCA loading drift, and local cell-type mean squared error (MSE), spatially smoothed leverage scores match or outperform alternatives. These results motivate joint spatial-transcriptomic sketching objectives to enable fast, unbiased analyses of increasingly large ST datasets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.